Scientists use animal models to study a wide range of diseases, but no single animal model encompasses all sequelae of a particular disease. Preclinical research on osteoarthritis remains challenging because its onset is influenced by different mechanisms, resulting in various symptoms such as joint pain, inflammatory flares, and cartilage lesions. In this webinar brought to you by Inotiv, Jed Pheneger and Alison Bendele will discuss various animal models for osteoarthritis drug development and compare lesion morphologies and pathological mediators of osteoarthritis in these models.
Topics to be covered
- Advantages and limitations of current preclinical osteoarthritis models
- Key morphologic and pathogenic features of various osteoarthritis models
- Selecting the most applicable animal model for osteoarthritis drug development
Wednesday, August 2nd, 2023 | 2:30 PM - 4:00 PM Eastern Time
This webinar will be available to view live and on demand.
Speakers
Jed Pheneger
Senior Director of Pharmacology – Inflammation
Inotiv
Alison Bendele, DVM, PhD, DACVP
Pathologist
Inotiv